This round of funding enables the business to extend the management team and more effectively pursue an aggressive sales and marketing strategy in the UK and the US.
To support the growth strategy, 11health has appointed James Barbour-Smith as executive chairman. He will be responsible for the continued financial growth and strategic direction of the firm. James brings to the role over 20 years of global experience in developing and building businesses through his role as Head of Portfolio at Gresham Private Equity.
As part of its US growth strategy, 11health has hired Matthew Wilder, who joins the US team as vice president of sales. Wilder will be responsible for implementing sales and driving growth across America. He has extensive experience in medical sales and played for the American Football Team, The Miami Dolphins. The firm is in advanced discussions and trials with a number of well-respected hospitals in the U.S. including: Stanford University, Massachusetts General and Cedars Sinai (LA).
Michael Seres, founder of 11health, said: “We are pleased to welcome James and Matthew to 11health and look forward to the unique contribution that they will bring to the business. As a connected device company, focused initially on stoma care, our ambition is to become the leading connected device across all medical bags and pouches.
“These important new appointments, along with this funding will reinforce our growing presence in the U.S. and British markets, and help bring our global vision to reality.
“We are moving forward at a tremendous pace, and this additional funding will really help us accelerate our product development especially into new markets and build out our sales teams in the UK and in the U.S.”
Michael Seres, a long-term patient turned innovator, founded 11health in 2013 with Adam Bloom when he created the Ostom-i Alert device from his hospital bed, after being the 11th person in the UK to undergo a small bowel transplant in 2011.